Carmina E, Lo Coco R, Lanzara P, Jannì A
Acta Endocrinol (Copenh). 1979 Aug;91(4):609-15. doi: 10.1530/acta.0.0910609.
In 11 untreated acromegalic patients the plasma GH levels were determined after the acute administration of bromocriptine, haloperidol, pimozide (only in 8 patients) and of placebo. A 50% or more suppression of the basal GH levels was arbitrarily defined as a positive response to bromocriptine. Five patients displayed a negative response to bromocriptine. Of these, 4 responded to both antidopaminergic drugs. We conclude that the acute administration of antidopaminergic drugs reduces the GH secretion in some bromocriptine-insensitive acromegalic patients. Therapeutical implications will require further studies.
在11例未经治疗的肢端肥大症患者中,在急性给予溴隐亭、氟哌啶醇、匹莫齐特(仅8例患者)和安慰剂后测定血浆生长激素(GH)水平。基础GH水平抑制50%或更多被任意定义为对溴隐亭的阳性反应。5例患者对溴隐亭反应阴性。其中,4例对两种抗多巴胺能药物均有反应。我们得出结论,急性给予抗多巴胺能药物可降低一些对溴隐亭不敏感的肢端肥大症患者的GH分泌。治疗意义还需要进一步研究。